Study wrapper · #1029
Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.
Editor's note
A large retrospective target-trial-emulation study using US electronic health records, reporting that initiation of semaglutide or tirzepatide was associated with lower rates of alcohol-related hospitalization across four emulated trials. The use of active comparators, propensity-score methods, and a negative-control outcome strengthens the analysis, but as an observational study it establishes association rather than causation and remains subject to residual confounding. The consistency of the effect across diabetes and obesity subgroups is notable.
Plain-language abstract
In a large US study of over 40,000 adults with alcohol use disorder plus diabetes or obesity, starting semaglutide or tirzepatide was associated with substantially lower rates of alcohol-related hospitalizations and emergency visits. The strongest associations appeared among those specifically treated for alcohol use disorder.